Restylane Volyme Shows Sustained Improvement in Temple Hollowing in China Study
The injectable, known as Restylane Contour in the US, achieved a 94.4% responder rate at six months, with improvements sustained through 12 months.
The injectable, known as Restylane Contour in the US, achieved a 94.4% responder rate at six months, with improvements sustained through 12 months.
Scott R. Miller, MD, FACS, examines how commodification threatens plastic surgery’s emphasis on judgment and craft—and makes the case for a low-volume, high-quality approach to patient care.
The annual report from the American Society of Plastic Surgeons shows which cosmetic procedures were most in demand in 2025 and where the biggest growth occurred.
Health Canada's licensing of the PicoPretty Q-Switched ND:YAG Laser expands Canadian providers' access to a multi-mode platform for tattoo removal, pigmentation treatment, skin rejuvenation, vascular applications, and hair reduction.
Procode has raised a $10 million Series A financing to expand its AI-powered medical billing platform into additional surgical specialties, pursue acquisitions, and grow its ambulatory surgery center billing business. The announcement follows the publication of a peer-reviewed study evaluating the company's AI surgical coding technology in Plastic & Reconstructive Surgery (PRS) Global Open.